LOPINAVIR O-ACYL
UNII MY30811HBP

Substance Identification & Data

This profile provides standardized clinical and technical data for Lopinavir O-acyl, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MY30811HBP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 1599828. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
MY30811HBP
CAS Registry Number
N/A
RxNorm Concept ID
1599828

Detailed Substance Profile

Preferred Name
LOPINAVIR O-ACYL
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C46H62N6O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
MXYNNFOWSAAISV-GMKKBYQQSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
76962151
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C([C@H](C(C)C)N1CCCNC1=O)(=O)O[C@H]([C@H](Cc2ccccc2)NC(COc3c(cccc3C)C)=O)C[C@H](Cc4ccccc4)NC([C@H](C(C)C)N5CCCNC5=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lopinavir O-acyl. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL) 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE, (S)-
LOPINAVIR IMPURITY O [EP IMPURITY]
LOPINAVIR O-ACYL
LOPINAVIR O-ACYL [USP IMPURITY]

Systematic Nomenclature

(1S,3S)-1-((1S)-1-((2-(2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-2-PHENYLETHYL)-3-(((2S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOYL)AMINO)-4-PHENYLBUTYL (2S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE
(2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL (S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE
(S)-((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL( 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE
(S)-((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL) 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound